Search - tctmd.com

Displaying 121 - 140 of 188

Sort: Relevancy | Date

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2018

Caitlin E. Cox

June 01, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2018

Caitlin E. Cox

April 30, 2018

News Daily News

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Shelley Wood

April 13, 2018

News Daily News

Real-World AV Replacement in France: All Eyes on Mortality as Volumes Go Up and Patient Risk Declines

Yael L. Maxwell

April 10, 2018

News Conference News ACC 2018

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Caitlin E. Cox

March 19, 2018

News Daily News

FDA Posts Outdated Alert for Sapien 3 Transapical Delivery System

Shelley Wood

January 11, 2018

News Daily News

Surgical Aortic Valve Repair Effective, Durable in Experienced Hands

Caitlin E. Cox

December 21, 2017

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

News Daily News

EVAR Shown to IMPROVE Outcomes Over Surgery for Ruptured AAA Patients

L.A. McKeown

November 17, 2017

News Conference News AHA 2017

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Shelley Wood

November 12, 2017

News Conference News TCT 2017

Early Pilot Study Results Show Symptom Improvement With TMVR

Michael O'Riordan

November 07, 2017

News Conference News TCT 2017

MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months

TCT Daily Staff

November 06, 2017

News Conference News TCT 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Yael L. Maxwell

November 01, 2017

Presentation TCT 2017

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation

Comparative Outcomes of US Patients With Advanced Renal Dysfunction Undergoing TAVR

October 17, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

Advertisement

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

TCTMD’s Top 10 Most Popular Stories for May 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

TCTMD’s Top 10 Most Popular Stories for April 2018

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Real-World AV Replacement in France: All Eyes on Mortality as Volumes Go Up and Patient Risk Declines

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

FDA Posts Outdated Alert for Sapien 3 Transapical Delivery System

Surgical Aortic Valve Repair Effective, Durable in Experienced Hands

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

EVAR Shown to IMPROVE Outcomes Over Surgery for Ruptured AAA Patients

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Early Pilot Study Results Show Symptom Improvement With TMVR

MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Comparative Outcomes of US Patients With Advanced Renal Dysfunction Undergoing TAVR

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content